Sign up to save your podcasts
Or
Share Episode 43: Clinical Study Start Up
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 43: Clinical Study Start Up
In this QCast episode, co-hosts Jullia and Tom explore clinical study start up and why it has such a direct effect on how a trial runs once sites begin opening. They look at what study start up actually includes, from feasibility and budgeting to contracts, ethics, and regulatory submissions, and explain why early choices in this phase can shape timelines, site activation, and the amount of operational disruption carried into enrolment.
Key Takeaways
- Feasibility should test whether the study can really run as planned. That means looking beyond protocol intent to site capacity, patient availability, staffing, and day-to-day operational burden.
- Delays in study start up do not come only from ethics or regulatory review. Budget development, contract negotiation, handoffs, and unclear ownership can quietly add significant waiting time.
- Start up becomes more predictable when teams treat it as a controlled process. Clear accountability, parallel work where appropriate, and measurement of cycle time and delays all help reduce avoidable slowdowns.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
- Clinical Data Capture & Management
- Biostatistics & Statistical Consultancy
- Statistical Programming & PK/PD Analysis
- Medical Writing & Pharmacovigilance
- Regulatory & Submission Support
- AI & Automation
- Post-Marketing Safety & Real-World Data
Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
View all episodes
By QuanticateIn this QCast episode, co-hosts Jullia and Tom explore clinical study start up and why it has such a direct effect on how a trial runs once sites begin opening. They look at what study start up actually includes, from feasibility and budgeting to contracts, ethics, and regulatory submissions, and explain why early choices in this phase can shape timelines, site activation, and the amount of operational disruption carried into enrolment.
Key Takeaways
- Feasibility should test whether the study can really run as planned. That means looking beyond protocol intent to site capacity, patient availability, staffing, and day-to-day operational burden.
- Delays in study start up do not come only from ethics or regulatory review. Budget development, contract negotiation, handoffs, and unclear ownership can quietly add significant waiting time.
- Start up becomes more predictable when teams treat it as a controlled process. Clear accountability, parallel work where appropriate, and measurement of cycle time and delays all help reduce avoidable slowdowns.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
- Clinical Data Capture & Management
- Biostatistics & Statistical Consultancy
- Statistical Programming & PK/PD Analysis
- Medical Writing & Pharmacovigilance
- Regulatory & Submission Support
- AI & Automation
- Post-Marketing Safety & Real-World Data
Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.